I am looking forward to hearing from the FDA about how data on this year's vaccine effectiveness helped to inform the decisionmaking for next year.

This year, again, we are experiencing a severe flu season caused by the H3N2.

These are cruel inflictions from an administration who claims to be addressing the opioid crisis.

I have just received a letter from our colleague, Diana DeGette, with a statement from the City and County of Denver...

Well, good news. Four courts have already said that your Department can't stop them from getting abortions.

this seems like an unacceptable intrusion into the attorney-client relationship to me.

Excessive consolidation leaves consumers with few choices, which not only limits their care options but also has the potential to raise prices.

It is clear that the delivery of care is changing, and not always to the benefit of patients and payers.

Consolidation does not always have to be negative.

As I said in my opening statement, my colleague, Tom Reed, and I have been looking into insulin prices, and I think that our investigation, the facts we've learned, have broad implications from the consolidation issues here today.

When Medicare's expenditures go up, the taxpayers suffer as well.

Consumers need advocates on their behalf.

I have got strong reservations about undermining or loosening the DQSA's prescription requirement in any way, given the consideration that any move in that direction could have an impact on patient safety.

As Mr. Green mentioned, he and Congressman Griffith and I worked really hard after that terrible tragedy of the New England Compounding Center to come up with our Compounding Quality Act, which was subsequently folded into the Drug Quality…

Thank you so much, Mr. Chairman. As you know, food safety is not a new issue for this committee.

Now, this was frustrating to all of us because lives were at stake.

If you think that there's more authority this committee needs to give to the agency to bolster that, and if you think there's more resources or stability of resources to do this hiring, let us know, because we--this is one of these…

We are prohibited from using Brownfields money for Superfund cleanup, right?

Some do, some don't.

But I think the profit has gotten way out of control in many cases. I want to make sure the potential for profit is truly incentivizing innovation, not just lining investors' pockets.

Will PhRMA, AHIP, and PCMA each agree to work with your member companies to share information with us about your contract with other supply chain players including sharing specific examples of contract terms?

But they don't always go back in the form of lower drug prices.

I want to ensure that we continue to encourage innovation and development of new cures and the ability to profit as part of that when you are in such a risky business.

You're not going to help.

We need to make sure that they're getting services that are useful and that are actually treating them.